Works matching AU Oldgren, Jonas

Results: 74
    1

    Associations between physical activity and CVD-related metabolomic and proteomic biomarkers.

    Published in:
    PLoS ONE, 2025, v. 20, n. 6, p. 1, doi. 10.1371/journal.pone.0325720
    By:
    • Ekblom, Örjan;
    • Björkbacka, Harry;
    • Börjesson, Mats;
    • Ekblom-Bak, Elin;
    • Blomberg, Anders;
    • Caidahl, Kenneth;
    • Ehrenborg, Ewa;
    • Engström, Gunnar;
    • Engvall, Jan;
    • Erlinge, David;
    • Fall, Tove;
    • Gigante, Bruna;
    • Gummesson, Anders;
    • Jernberg, Tomas;
    • Lind, Lars;
    • Molnar, David;
    • Oldgren, Jonas;
    • Rawshani, Aidin;
    • Sundström, Johan;
    • Söderberg, Stefan
    Publication type:
    Article
    2

    Dabigatran Dual Therapy vs Warfarin Triple Therapy Post-Percutaneous Coronary Intervention in Patients with Atrial Fibrillation With/Without a Proton Pump Inhibitor: A Pre-Specified Analysis of the RE-DUAL PCI Trial.

    Published in:
    Drugs, 2020, v. 80, n. 10, p. 995, doi. 10.1007/s40265-020-01323-x
    By:
    • Nicolau, José C.;
    • Bhatt, Deepak L.;
    • Hohnloser, Stefan H.;
    • Kimura, Takeshi;
    • Lip, Gregory Y. H.;
    • Miede, Corinna;
    • Nordaby, Matias;
    • Oldgren, Jonas;
    • Steg, Philippe Gabriel;
    • ten Berg, Jurriën M.;
    • Godoy, Lucas C.;
    • Cannon, Christopher P.
    Publication type:
    Article
    3

    Evaluation of the Age, Biomarkers, and Clinical History–Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials.

    Published in:
    JAMA Network Open, 2020, v. 3, n. 9, p. e2015943, doi. 10.1001/jamanetworkopen.2020.15943
    By:
    • Hijazi, Ziad;
    • Oldgren, Jonas;
    • Lindbäck, Johan;
    • Alexander, John H.;
    • Alings, Marco;
    • De Caterina, Raffaele;
    • Eikelboom, John W.;
    • Ezekowitz, Michael D.;
    • Held, Claes;
    • Huber, Kurt;
    • Hylek, Elaine M.;
    • Granger, Christopher B.;
    • Lopes, Renato D.;
    • Vinereanu, Dragos;
    • Siegbahn, Agneta;
    • Wallentin, Lars
    Publication type:
    Article
    4

    Effects of 6 weeks of treatment with dapagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: A randomized, placebo‐controlled, exploratory study.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 7, p. 1505, doi. 10.1111/dom.14363
    By:
    • Oldgren, Jonas;
    • Laurila, Sanna;
    • Åkerblom, Axel;
    • Latva‐Rasku, Aino;
    • Rebelos, Eleni;
    • Isackson, Henrik;
    • Saarenhovi, Maria;
    • Eriksson, Olof;
    • Heurling, Kerstin;
    • Johansson, Edvin;
    • Wilderäng, Ulrica;
    • Karlsson, Cecilia;
    • Esterline, Russell;
    • Ferrannini, Ele;
    • Oscarsson, Jan;
    • Nuutila, Pirjo
    Publication type:
    Article
    5
    6
    7
    8
    9
    10

    Praktyczny przewodnik European Heart Rhythm Association dotyczący stosowania doustnych leków przeciwkrzepliwych niebędących antagonistami witaminy K u pacjentów z migotaniem przedsionków: obszerne streszczenie (2018).

    Published in:
    Polish Heart Journal / Kardiologia Polska, 2018, v. 76, n. 9, p. 1283, doi. 10.5603/KP.2018.0180
    By:
    • Steffel, Jan;
    • Verhamme, Peter;
    • Potpara, Tatjana S.;
    • Albaladejo, Pierre;
    • Antz, Matthias;
    • Desteghe, Lien;
    • Haeusler, Karl Georg;
    • Oldgren, Jonas;
    • Reinecke, Holger;
    • Roldan-Schilling, Vanessa;
    • Rowell, Nigel;
    • Sinnaeve, Peter;
    • Collins, Ronan;
    • Camm, A. John;
    • Heidbüchel, Hein
    Publication type:
    Article
    11

    Wytyczne ESC dotyczące leczenia migotania przedsionków w 2016 roku, opracowane we współpracy z EACTS.

    Published in:
    Polish Heart Journal / Kardiologia Polska, 2016, v. 74, n. 12, p. 1359, doi. 10.5603/KP.2016.0172
    By:
    • Kirchhof, Paulus;
    • Benussi, Stefano;
    • Kotecha, Dipak;
    • Ahlsson, Anders;
    • Atar, Dan;
    • Casadei, Barbara;
    • Castella, Manuel;
    • Diener, Hans-Christoph;
    • Heidbuchel, Hein;
    • Hendriks, Jeroen;
    • Hindricks, Gerhard;
    • Manolis, Antonis S.;
    • Oldgren, Jonas;
    • Popescu, Bogdan Alexandru;
    • Schotten, Ulrich;
    • Van Putte, Bart;
    • Vardas, Panagiotis
    Publication type:
    Article
    12

    The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE‐DUAL PCI subgroup analysis and comparison to other dual antithrombotic therapy trials)

    Published in:
    Clinical Cardiology, 2021, v. 44, n. 7, p. 1002, doi. 10.1002/clc.23649
    By:
    • Eccleston, David S.;
    • Kim, Joseph M.;
    • ten Berg, Jurien M.;
    • Steg, P. Gabriel;
    • Bhatt, Deepak L.;
    • Hohnloser, Stefan H.;
    • Veer, Anne;
    • Nordaby, Matias;
    • Miede, Corinna;
    • Kimura, Takeshi;
    • Lip, Gregory Y. H.;
    • Oldgren, Jonas;
    • Cannon, Christopher P.
    Publication type:
    Article
    13
    14
    15

    Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention With Stenting

    Published in:
    Clinical Cardiology, 2016, v. 39, n. 10, p. 555, doi. 10.1002/clc.22572
    By:
    • Cannon, Christopher P.;
    • Gropper, Savion;
    • Bhatt, Deepak L.;
    • Ellis, Stephen G.;
    • Kimura, Takeshi;
    • Lip, Gregory Y.H.;
    • Steg, Ph. Gabriel;
    • Berg, Jurriën M.;
    • Manassie, Jenny;
    • Kreuzer, Jörg;
    • Blatchford, Jon;
    • Massaro, Joseph M.;
    • Brueckmann, Martina;
    • Ferreiros Ripoll, Ernesto;
    • Oldgren, Jonas;
    • Hohnloser, Stefan H.
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22

    Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial.

    Published in:
    European Heart Journal, 2019, v. 40, n. 19, p. 1553, doi. 10.1093/eurheartj/ehz059
    By:
    • Oldgren, Jonas;
    • Steg, Philippe Gabriel;
    • Hohnloser, Stefan H;
    • Lip, Gregory Y H;
    • Kimura, Takeshi;
    • Nordaby, Matias;
    • Brueckmann, Martina;
    • Kleine, Eva;
    • Berg, Jurrien M ten;
    • Bhatt, Deepak L;
    • Cannon, Christopher P
    Publication type:
    Article
    23
    24

    Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials.

    Published in:
    European Heart Journal, 2018, v. 39, n. 19, p. 1726, doi. 10.1093/eurheartj/ehy162
    By:
    • Golwala, Harsh B;
    • Cannon, Christopher P;
    • Steg, Ph Gabriel;
    • Doros, Gheorghe;
    • Qamar, Arman;
    • Ellis, Stephen G;
    • Oldgren, Jonas;
    • Berg, Jurrien M ten;
    • Kimura, Takeshi;
    • Hohnloser, Stefan H
    Publication type:
    Article
    25
    26
    27
    28

    Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society.

    Published in:
    2022
    By:
    • Gorog, Diana A;
    • Gue, Ying X;
    • Chao, Tze-Fan;
    • Fauchier, Laurent;
    • Ferreiro, Jose Luis;
    • Huber, Kurt;
    • Konstantinidis, Stavros V;
    • Lane, Deirdre A;
    • Marin, Francisco;
    • Oldgren, Jonas;
    • Potpara, Tatjana;
    • Roldan, Vanessa;
    • Rubboli, Andrea;
    • Sibbing, Dirk;
    • Tse, Hung-Fat;
    • Vilahur, Gemma;
    • Lip, Gregory Y H
    Publication type:
    journal article
    29
    30

    2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation.

    Published in:
    2021
    By:
    • Steffel, Jan;
    • Collins, Ronan;
    • Antz, Matthias;
    • Cornu, Pieter;
    • Desteghe, Lien;
    • Haeusler, Karl Georg;
    • Oldgren, Jonas;
    • Reinecke, Holger;
    • Roldan-Schilling, Vanessa;
    • Rowell, Nigel;
    • Sinnaeve, Peter;
    • Vanassche, Thomas;
    • Potpara, Tatjana;
    • Camm, A John;
    • Heidbüchel, Hein;
    • reviewers, External;
    • External reviewers:;
    • Lip, Gregory Y H;
    • Deneke, Thomas;
    • Dagres, Nikolaos
    Publication type:
    journal article
    31

    Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysis.

    Published in:
    2020
    By:
    • Kloosterman, Mariëlle;
    • Oldgren, Jonas;
    • Conen, David;
    • Wong, Jorge A;
    • Connolly, Stuart J;
    • Avezum, Alvaro;
    • Yusuf, Salim;
    • Ezekowitz, Michael D;
    • Wallentin, Lars;
    • Ntep-Gweth, Marie;
    • Joseph, Philip;
    • Barrett, Tyler W;
    • Tanosmsup, Supachai;
    • McIntyre, William F;
    • Lee, Shun Fu;
    • Parkash, Ratika;
    • Amit, Guy;
    • Grinvalds, Alex;
    • Gelder, Isabelle C Van;
    • Healey, Jeff S
    Publication type:
    journal article
    32

    The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary.

    Published in:
    2018
    By:
    • Steffel, Jan;
    • Verhamme, Peter;
    • Potpara, Tatjana S;
    • Albaladejo, Pierre;
    • Antz, Matthias;
    • Desteghe, Lien;
    • Haeusler, Karl Georg;
    • Oldgren, Jonas;
    • Reinecke, Holger;
    • Roldan-Schilling, Vanessa;
    • Georg Haeusler, Karl;
    • Rowell, Nigel;
    • Sinnaeve, Peter;
    • Collins, Ronan;
    • Camm, A John;
    • Heidbüchel, Hein;
    • ESC Scientific Document Group
    Publication type:
    journal article
    33
    34

    2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

    Published in:
    2016
    By:
    • Kirchhof, Paulus;
    • Benussi, Stefano;
    • Kotecha, Dipak;
    • Ahlsson, Anders;
    • Atar, Dan;
    • Casadei, Barbara;
    • Castella, Manuel;
    • Diener, Hans-Christoph;
    • Heidbuchel, Hein;
    • Hendriks, Jeroen;
    • Hindricks, Gerhard;
    • Manolis, Antonis S;
    • Oldgren, Jonas;
    • Popescu, Bogdan Alexandru;
    • Schotten, Ulrich;
    • Van Putte, Bart;
    • Vardas, Panagiotis;
    • Agewall, Stefan;
    • Camm, John;
    • Baron Esquivias, Gonzalo
    Publication type:
    journal article
    35
    36
    37

    Author reply.

    Published in:
    2014
    By:
    • Heidbuchel, Hein;
    • Verhamme, Peter;
    • Alings, Marco;
    • Antz, Matthias;
    • Hacke, Werner;
    • Oldgren, Jonas;
    • Sinnaeve, Peter;
    • John Camm, A;
    • Kirchhof, Paulus;
    • all the authors of the EHRA Practical Guide:
    Publication type:
    Journal Article
    38
    39
    40

    Author reply.

    Published in:
    EP: Europace, 2014, v. 16, n. 1, p. 151
    By:
    • Heidbuchel, Hein;
    • Verhamme, Peter;
    • Alings, Marco;
    • Antz, Matthias;
    • Hacke, Werner;
    • Oldgren, Jonas;
    • Sinnaeve, Peter;
    • John Camm, A.;
    • Kirchhof, Paulus
    Publication type:
    Article
    41
    42
    43
    44

    Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial.

    Published in:
    Journal of the American Heart Association, 2024, v. 13, n. 7, p. 1, doi. 10.1161/JAHA.123.033720
    By:
    • Gkarmiris, Konstantinos I.;
    • Lindbäck, Johan;
    • Alexander, John H.;
    • Granger, Christopher B.;
    • Kastner, Peter;
    • Lopes, Renato D.;
    • Ziegler, André;
    • Oldgren, Jonas;
    • Siegbahn, Agneta;
    • Wallentin, Lars;
    • Hijazi, Ziad
    Publication type:
    Article
    45

    Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS<sub>2</sub> Score: A Subgroup Analysis of the RE-LY Trial.

    Published in:
    Annals of Internal Medicine, 2011, v. 155, n. 10, p. 660, doi. 10.7326/0003-4819-155-10-201111150-00004
    By:
    • Oldgren, Jonas;
    • Alings, Marco;
    • Darius, Harald;
    • Diener, Hans-Christoph;
    • Eikelboom, John;
    • Ezekowitz, Michael D.;
    • Kamensky, Gabriel;
    • Reilly, Paul A.;
    • Sean Yang;
    • Yusuf, Salim;
    • Wallentin, Lars;
    • Connolly, Stuart J.
    Publication type:
    Article
    46
    47

    2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

    Published in:
    European Heart Journal, 2016, v. 37, n. 38, p. 2893, doi. 10.1093/eurheartj/ehw210
    By:
    • Kirchhof, Paulus;
    • Benussi, Stefano;
    • Kotecha, Dipak;
    • Ahlsson, Anders;
    • Atar, Dan;
    • Casadei, Barbara;
    • Castella, Manuel;
    • Diener, Hans-Christoph;
    • Heidbuchel, Hein;
    • Hendriks, Jeroen;
    • Hindricks, Gerhard;
    • Manolis, Antonis S.;
    • Oldgren, Jonas;
    • Popescu, Bogdan Alexandru;
    • Schotten, Ulrich;
    • Van Putte, Bart;
    • Vardas, Panagiotis
    Publication type:
    Article
    48
    49
    50